Treace Medical Concepts Inc (TMCI) - Total Liabilities
Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) has total liabilities worth $107.40 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TMCI cash flow conversion to assess how effectively this company generates cash.
Treace Medical Concepts Inc - Total Liabilities Trend (2019–2024)
This chart illustrates how Treace Medical Concepts Inc's total liabilities have evolved over time, based on quarterly financial data. Check TMCI cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Treace Medical Concepts Inc Competitors by Total Liabilities
The table below lists competitors of Treace Medical Concepts Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RTX A/S
CO:RTX
|
Denmark | Dkr154.16 Million |
|
Yibitas Yozgat Isci Birligi Insaat Malzemeleri Ticaret Sanayi AS
IS:YBTAS
|
Turkey | TL17.78 Million |
|
Lam Soon (Thailand) Public Company Limited
BK:LST
|
Thailand | ฿2.62 Billion |
|
Averlogic Technologies
TWO:6198
|
Taiwan | NT$1.45 Billion |
|
Forrester Research Inc
NASDAQ:FORR
|
USA | $256.51 Million |
|
Roto Pumps Limited
NSE:ROTO
|
India | Rs907.96 Million |
|
Smith & Nephew PLC
LSE:SN
|
UK | GBX5.17 Billion |
|
Diamond Building Products Public Company Limited
BK:DRT
|
Thailand | ฿1.67 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Treace Medical Concepts Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Treace Medical Concepts Inc stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Treace Medical Concepts Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Treace Medical Concepts Inc (2019–2024)
The table below shows the annual total liabilities of Treace Medical Concepts Inc from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $104.20 Million | -8.57% |
| 2023-12-31 | $113.97 Million | +15.71% |
| 2022-12-31 | $98.50 Million | +106.28% |
| 2021-12-31 | $47.75 Million | +16.37% |
| 2020-12-31 | $41.03 Million | +54.51% |
| 2019-12-31 | $26.55 Million | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lap… Read more